
|Articles|August 1, 1998
Supplements and Featured Publications
- Predicting the Probability of Achieving NCEP LDL-C Treatment Goals Using HMG-CoA Reductase Inhibitor
- Volume 4
- Issue 8 Suppl
Predicting the Probability of Achieving NCEP LDL-C Treatment Goals Using HMG-CoA Reductase Inhibitor Monotherapy
Author(s)Ann S.M. Harada, MPH, Michael B. Nichol, PhD
Advertisement
Articles in this issue
about 27 years ago
Participating Facultyabout 27 years ago
Selected Abstractsabout 27 years ago
CME / CPE Quizabout 27 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research COuld Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
4
Value-Based Care Interventions and Management of CKD Progression
5